JAK-1 inhibitor upadacitinib advances to phase III for refractory Crohn’sMay 16, 2017IBD & Intestinal Disorders
Ribaxamase prevented C. difficile infections by protecting microbiomeMay 11, 2017IBD & Intestinal Disorders
Adalimumab is good first-line anti-TNF therapy for pediatric Crohn’s diseaseMay 9, 2017IBD & Intestinal Disorders
VIDEO: Registry study will follow 4,000 fecal transplant patients for 10 yearsMay 8, 2017IBD & Intestinal Disorders
VIDEO: Indomethacin slashes post-ERCP pancreatitis risk in primary sclerosing cholangitisMay 7, 2017Liver Disease
